92765 ā
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#2NOVEL 9H-FLUORENE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
#3MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#4SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#5Vegetable oil-based material as a substitute for carnauba wax
#6INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR
#7Method for making propenamide compound
#8Method of treating colorectal cancer
#9Bis-propenamide compounds and methods of treating cancer
#10Modulators of Sestrin-GATOR2 interaction and uses thereof
#11Vegetable oil-based material as a substitute for carnauba wax
#12Derivatives of sobetirome
#13Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same
#14Modulators of Sestrin-GATOR2 interaction and uses thereof
#15Activatable two-component photosensitizers
#16Kappa opioid agonists and uses thereof
#17Modulators of sestrin-GATOR2 interaction and uses thereof
#18Vegetable oil-based material as a substitute for carnauba wax
#19Activatable two-component photosensitizers
#20N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same
#21Kappa opioid agonists and uses thereof
#22NOVEL CANNABINOID RECEPTOR 2 (CB2) INVERSE AGONISTS AND THERAPEUTIC POTENTIAL FOR MULTIPLE MYELOMA AND OSTEOPOROSIS BONE DISEASES
#23Bacterial efflux pump inhibitors
#24Kappa opioid agonists and uses thereof
#25NOVEL PHENICOL ANTIBACTERIALS
#26Substituted cinnamic acid amides for treating pain
#27Substituted 4-aminocyclohexane derivatives
#28Phenicol antibacterials
#29Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#30DENDRIMERS AS NON-VIRAL VEHICLES FOR GENE THERAPY
#31Substituted 4-aminocyclohexane derivatives
#32Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases
#33Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#342-ARYL-PROPIONAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#35Substituted 4-aminocyclohexane derivatives
#36Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#37Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#38Modulators of G protein-coupled receptor 88
#39Diaminoalkane aspartic protease inhibitors
#40ETHANOLAMINE DERIVATIVES USEFUL AS BACE INHIBITORS
#41Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#42N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#43Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#44SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#45Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them
#46Synthesis of quaternary salt compounds
#47Diaminoalkane aspartic protease inhibitors
#48New amino-alkyl-amide derivatives as CCR3 receptor ligands
#49Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#50New amino-alkyl-amide derivatives as CCR3 receptor ligands
#51Substituted Benzyloxy-Phenylmethylamide Derivatives
#52Phenacyl 2-Hydroxy-3-Diaminoalkanes
#53Sigma Receptor Ligands
#54Substituted Hydroxyethylamines
#55Process for production of molecular devices
#56Process for production of molecular devices
#57OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#58Hydroxypropyl Amides for the Treatment of Alzheimer's Disease
#59N,Nā²-substituted-1,3-diamino-2-hydroxypropane derivatives
#60Aniline derivatives
#61UII-modulating compounds and their use
#62N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#63Tertiary amino compounds having opioid receptor affinity
#64Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#65Novel anticancer compounds
#66Process for production of molecular devices
#67Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
#68Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
#69Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#70Phenacyl 2-hydroxy-3-diaminoalkanes
#71Pharmaceutical composition with cytotoxic activity on colorectal cancer cells